ApoGen Biotechnologies expands series A financing to $11m

Image: ApoGen Biotechnologies is focused on development of new class of drugs targeting drivers of cancer genomic mutations. Photo: courtesy of David Castillo Dominici / FreeDigitalPhotos.net.